AzPA Pharmacy Flash

• Pharmacist-Led Interventions Show Promise in Improving COPD Outcomes
  A study in Medical Principles and Practice found that pharmacist-led interventions improved chronic obstructive pulmonary disease outcomes among patients, emphasizing the correct use of medications and therapies.
• Kirsty, an Interchangeable Biosimilar to Novolog, Gets FDA Approval
  The FDA has approved Kirsty™, an interchangeable biosimilar to Novolog®, to improve glycemic control in diabetes patients. It is the first rapid-acting insulin biosimilar and the fourth approved by the FDA.
• FDA Greenlights UV Technology That Could Make Raw Milk Safer to Consume
  Tamarack Biotics has received FDA approval for its UV light technology, TruActive, which eliminates harmful pathogens in raw milk, preserving enzymes, proteins and immunity-supporting compounds.